The money
Kismet, a Melbourne healthcare start-up raised AUD 32.5m in its seed financing round, with Singapore's MassMutual Ventures becoming its new investor.
This is a year after Kismet CEO Mark Woodland shared with Smart Company that the startup was humbled and grateful for the $12.5 million capital from a funding round, which was led by global consumer internet group Prosus Ventures and venture capital firm Airtree Ventures.
Early-stage investors include Flying Fox, Black Nova, and Airtree Ventures, invested AUD 4m in a pre-seed funding round in the year before
The Growth
The company, whose annual recurring revenue is expected to reach AUD 20m this year.
The Pain Kismet is trying to solve and the painkiller
The Pain
Healthcare's fractured system complicates managing health plans and services, increasing costs and limiting access.
The Painkiller
Kismet improves the way people access healthcare and disability services.
They connect the physical and digital worlds to enabling greater access to disability and healthcare services at the tap of a button.
No comments:
Post a Comment